Anthony G Coyne

Affiliations: 
University of Cambridge, Cambridge, England, United Kingdom 
Area:
Fragment-based drug discovery
Google:
"Anthony Coyne"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bedwell E, McCarthy WJ, Coyne AG, et al. (2022) Development of potent inhibitors by fragment-linking strategies. Chemical Biology & Drug Design
Thomas SE, McCarthy WJ, El Bakali J, et al. (2022) Structural Characterization of Phosphopantetheine Adenylyl Transferase Ligand Interactions: Implications for Fragment-Based Drug Design. Frontiers in Molecular Biosciences. 9: 880432
Acebrón-García-de-Eulate M, Mayol-Llinàs J, Holland MTO, et al. (2022) Discovery of Novel Inhibitors of Uridine Diphosphate--Acetylenolpyruvylglucosamine Reductase (MurB) from , an Opportunistic Infectious Agent Causing Death in Cystic Fibrosis Patients. Journal of Medicinal Chemistry
Frederickson M, Selvam IR, Evangelopoulos D, et al. (2022) A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen). European Journal of Medicinal Chemistry. 230: 114105
Charoensutthivarakul S, Thomas SE, Curran A, et al. (2022) Development of Inhibitors of SAICAR Synthetase (PurC) from Using a Fragment-Based Approach. Acs Infectious Diseases
Scott DE, Francis-Newton NJ, Marsh ME, et al. (2021) A small-molecule inhibitor of the BRCA2-RAD51 interaction modulates RAD51 assembly and potentiates DNA damage-induced cell death. Cell Chemical Biology
Sabbah M, Mendes V, Vistal RG, et al. (2020) Correction to Fragment-Based Design of InhA Inhibitors. Journal of Medicinal Chemistry
Ribeiro JA, Hammer AJS, Libreros-Z Uacute Ntilde Iga GAES, et al. (2020) Using a fragment-based approach to identify alternative chemical scaffolds targeting dihydrofolate reductase from Mycobacterium tuberculosis. Acs Infectious Diseases
Thomas SE, Whitehouse AJ, Brown K, et al. (2020) Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification. Nucleic Acids Research
Sabbah M, Mendes V, Vistal RG, et al. (2020) Fragment-based design of Mycobacterium tuberculosis InhA inhibitors. Journal of Medicinal Chemistry
See more...